Editorial: advances in non-alcoholic fatty liver disease therapeutics: pathogenic mechanisms and targets

HIGHLIGHTS

• who: TYPE et al. from the University of Naples Federico II, Italy have published the paper: Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets, in the Journal: (JOURNAL) of 17/Oct/2022

SUMMARY

NAFLD, liver, therapy, gut, microbiome, NASH Editorial on the Research Topic Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets Non-alcoholic fatty liver disease (NAFLD) is a leading cause of advanced liver diseases worldwide and an increasing clinical and economic burden. As its complex pathophysiology and heterogeneity of disease phenotypes result . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.